BiochemProbe — Life Science Research Reagents

Trabodenoson free base · Synonyms: INO-8875

Trabodenoson, an adenosine mimetic, is a highly selective Adenosine A1 receptor agonist.

For research use only. Not for human or veterinary use.

Purity >98% Stock Inquire

Trabodenoson structure

CAS No.: 871108-05-3

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
100 mg USD 380.00 BP-02213-100mg In stock Get quote
250 mg USD 750.00 BP-02213-250mg In stock Get quote
500 mg USD 1,200.00 BP-02213-500mg In stock Get quote
1 g USD 1,950.00 BP-02213-1g In stock Get quote
2 g USD 3,140.00 BP-02213-2g In stock Get quote
3 g USD 3,750.00 BP-02213-3g In stock Get quote

Need another size or custom synthesis? Request a quote.

Description

Trabodenoson (INO-8875), an adenosine mimetic, is a highly selective Adenosine A1 receptor agonist. Trabodenoson (INO-8875) is used in the study for Primary Open-Angle Glaucoma[1].

Biological activity

In Vitro Trabodenoson treatment significantly increaseS MMP-2 activity and MMP-14 abundance, while decreasing fibronectin and collagen IV expression. In Vivo Trabodenoson (6.0%), demonstrating an average IOP drop of 2.45 ± 0.38 mm Hg in young mice over 7 days (downregulation). Topical trabodenoson significantly upregulates nestin expression in the ONH of induced eyes compared with vehicle-treated no-induced eyes. Trabodenoson-treated eyes have significantly reduced optic nerve (ON) edema compared with vehicle-treated eyes. RGC counts are higher in Trabodenoson-treated eyes compared to vehicle (74% versus 47% of the contralateral eye).

Identifiers

SMILES
O[C@H]1[C@@H](O[C@H](CO[N+]([O-])=O)[C@H]1O)N2C3=NC=NC(NC4CCCC4)=C3N=C2
InChIKey
AQLVRTWKJDTWQQ-SDBHATRESA-N

Specifications

MW (average)
380.3559
Formula
C15H20N6O6
CAS No.
871108-05-3
Physical state
Solid
Color
White to yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 3 years; 4℃ 2 years; In solvent -20℃ 1 year;

Solubility

soluble in DMSO

References

[1]. Guorong Li, et al. Trabodenoson, an Adenosine Mimetic With A1 Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice. Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):383-392.
[2]. Yan Guo, et al. Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION). Transl Vis Sci Technol. 2019 Dec 20;8(6):47.

Same research area

Search Inflammation/Immunology

Recently viewed